1h
ScienceAlert on MSNOzempic Literally Came From a Monster – And It's Not AloneThe toxic bite of a Gila monster can kill a human, but a specific ingredient in the cocktail of the lizard's venom is the ...
Many patients with overweight or obesity discontinue glucagon-like peptide-1 receptor agonist therapy within one year.
1d
GlobalData on MSNAscletis announces positive results in Phase Ib oral GLP-1RA trialThe Hong Kong company saw a reduction in body weight across both cohorts with no serious adverse events reported.
GLP-1s and nutrition: quality over restriction! Dr Almandoz shares how shifting from restrictive diets to evidence-based, ...
Energy provider Origin has been slapped with a $1.5 million fine for jeopardising the safety of domestic violence victims by disclosing their personal information. Picture: Carla Gottgens ...
ACCP Position Statement: "Ensuring the Appropriate Use of Glucagon-Like Peptide-1 Receptor Agonists"
Feb. 5, 2025 /PRNewswire/ -- The American College of Clinical Pharmacology ® (ACCP) published a recent Position Paper entitled "Ensuring the Appropriate Use of Glucagon-Like Peptide-1 Receptor ...
Liftoff was scheduled for 11:30 a.m. EST (1630 GMT), about 30 minutes later than Blue Origin's initially planned 11 a.m. ET launch time. You may like Blue Origin to launch New Shepard moon-gravity ...
The antidiabetic drugs coded included insulin, metformin, sulfonylurea, dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor antagonists ... in blood); uromodulin because of its renal ...
The NHS had been facing supply issues with glucagon-like peptide receptor agonists (GLP-1 RAs, or GLP-1 analogues), a range of drugs used for managing blood glucose levels in people with type 2 ...
Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Medicine Weight ...
Background: Despite their potential, Glucagon-like peptide-1 receptor agonists (GLP-1 RA) have not been well studied in cardiac amyloidosis (CA) as randomized trials on GLP-1 RA have excluded patients ...
Bangalore’s fresh produce brand, Origin Fresh, has secured $1 million in pre-seed funding, led by Aeravti Ventures. The round also featured strategic investments from a group of Ultra HNIs. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results